This Is MS Multiple Sclerosis Community: Knowledge & Support

Ezose Sciences Inc. today announced an alliance with Fast Forward, LLC, a subsidiary of the National Multiple Sclerosis Society, to use Ezose’s GlycanMap® technology in the discovery of biomarkers to help diagnose multiple sclerosis (MS) and improve disease management.

GlycanMap® technology enables the study of glycomics via automated analysis of the sugar molecules known as glycans that attach to proteins in the body and affect their biochemical function. The speed and high-throughput of this technology hold the potential to discover new biomarkers and targets that can improve the diagnosis and management of disease and enhance the efficiency of development of new therapeutic options.

To execute the research program, Ezose will collaborate with Anthony Reder, M.D., Professor of Neurology at the University of Chicago Medicine and a recognized expert in the clinical and laboratory research of multiple sclerosis. The research goal is to discover new biomarkers associated with MS, enabling earlier, surer diagnosis of the disease, distinguishing it from other neurological disorders, and to identify sub-types of MS. These biomarkers would then be incorporated in diagnostic tests to improve prognosis, aid in therapy selection, and evaluate response to therapy. They would also be useful in guiding the development of new therapies by increasing R&D speed and efficiency.

Under the terms of a sponsored research agreement, Ezose will receive up to $390,000 from Fast Forward to support the project....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3516

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis